| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Reviews |
1 Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children and 2 Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada
Requests for reprints: David Malkin, Division of Hematology/Oncology, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada M5G 1X8. Phone: 416-813-5348; Fax: 416-813-5327; E-mail: david.malkin{at}sickkids.ca.
Key Words: Cancer predisposition, risk, telomere, genetic modifier Predictive assays for carcinogenicity DNA damage and repair mechanisms Risk assessment p53
Germ-line mutations in specific genes predispose family members to cancer. Prediction of the exact tumor type and timing of cancer initiation is fundamental to the development of management strategies for these individuals. Recent advances in our understanding of the general processes that control cancer initiation may enable us to tailor more precise risk stratification. This, in turn, will lead to more effective early detection strategies, which would result in more favorable clinical outcomes. In this review, we highlight the steps and methods used to reach this futuristic model. [Cancer Res 2008;68(7):2053–7]
This article has been cited by other articles:
![]() |
G. C. Prendergast Risk Factors for Cancer: From Cell to Microenvironment Cancer Reviews Online Content, May 1, 2008; 2008(5): 9 - 9. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |